ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,127Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 944

$587K Total Retail Price of All Prescriptions

Rank: 136 out of 944

481 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 481 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,097 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LISINOPRIL 473 456 1 3
FUROSEMIDE 472 450 2 6
SIMVASTATIN 425 408 3 1
LEVOTHYROXINE SODIUM 400 337 4 2
METOPROLOL TARTRATE 383 358 5 8
OMEPRAZOLE 376 320 6 4
ATENOLOL 294 280 7 11
HYDROCHLOROTHIAZIDE 236 223 8 9
WARFARIN SODIUM 223 216 9 7
DONEPEZIL HCL 208 208 10 24
AMLODIPINE BESYLATE 201 200 11 5
FLUTICASONE PROPIONATE 198 194 12 40
NAMENDA 172 172 13 37
POTASSIUM CHLORIDE 159 159 14 15
CITALOPRAM HBR 152 152 15 19
TRAMADOL HCL 145 114 16 21
GABAPENTIN 139 118 17 18
LOSARTAN POTASSIUM 137 136 18 16
DIGOXIN 130 130 19 39
HYDROCODONE-ACETAMINOPHEN 129 107 S3 20 10
ATORVASTATIN CALCIUM 126 102 21 13
DIOVAN 126 126 21 38
RANITIDINE HCL 122 87 23 42
METOPROLOL SUCCINATE 117 113 24 14
TERAZOSIN HCL 113 113 25 99
ZOLPIDEM TARTRATE 109 99 26 25
METFORMIN HCL 109 84 26 12
DILTIAZEM ER 107 107 28 88
SERTRALINE HCL 104 83 29 23
ADVAIR DISKUS 100 98 30 31
ALLOPURINOL 96 96 31 22
PANTOPRAZOLE SODIUM 95 84 32 34
SPIRONOLACTONE 93 93 33 44
NIFEDIPINE ER 92 79 34 148
POLYETHYLENE GLYCOL 3350 91 91 35 41
AMITRIPTYLINE HCL 89 64 R 36 79
PRAVASTATIN SODIUM 78 76 37 17
TAMSULOSIN HCL 75 75 38 27
ENALAPRIL MALEATE 74 74 39 43
FENTANYL 73 52 S2 40 57
PREDNISONE 71 60 41 32
KLOR-CON 10 68 68 42 115
LOVASTATIN 68 68 42 26
OXYCODONE HCL 67 52 S2 44 50
FLOVENT HFA 65 50 45 152
AZITHROMYCIN 63 58 46 70
TRAZODONE HCL 56 54 47 45
PAROXETINE HCL 55 42 48 64
FINASTERIDE 55 55 48 83
QUETIAPINE FUMARATE 53 53 50 69
FLUOXETINE HCL 53 39 50 48
DETROL LA 52 39 52 159
TRIAMCINOLONE ACETONIDE 50 37 53 105
MORPHINE SULFATE ER 50 29 S2 53 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.